GO:0015835 peptidoglycan transport: Bacterial Cell Wall Recycling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015835 peptidoglycan transport describes the directed movement of peptidoglycan (murein) glycoconjugates into, out of, or within cells via transporters or pores.
• Peptidoglycan is a mesh-like polymer of glycan strands cross-linked by short peptides that surrounds most bacteria and is essential for osmotic stability and shape.
• Transport of peptidoglycan fragments is central to cell wall recycling, a process that recovers muropeptides from the periplasm for reuse in new cell wall synthesis.
• Escherichia coli uses multiple peptidoglycan recycling permeases, including AmpG and other transporters, with distinct substrate preferences and strategies.
• In mammals, the muropeptide transporter SLC46A2 mediates uptake of bacterial peptidoglycan fragments and is linked to immune activation in psoriasis.
• Peptidoglycan transport is a validated target space for antibiotics such as bacitracin, which interferes with the dephosphorylation of the lipid carrier undecaprenyl pyrophosphate, indirectly affecting peptidoglycan transport and synthesis.
Description
Peptidoglycan transport (GO:0015835) is the biological process that mediates the directed movement of peptidoglycans, a class of glycoconjugates found in bacterial cell walls, into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Peptidoglycan, also known as murein, forms a covalently closed meshwork that surrounds the cytoplasmic membrane of most bacteria and is essential for maintaining cell shape and resisting osmotic lysis. Because the peptidoglycan sacculus is continuously remodeled during growth and division, fragments are released and must be either recycled or transported across membranes, making transport an integral part of cell envelope homeostasis. In Gram-negative bacteria, peptidoglycan fragments (muropeptides) generated by lytic transglycosylases and endopeptidases are internalized into the cytoplasm for recycling, a process that requires dedicated permeases and transporters. In Mycobacterium tuberculosis and other mycobacteria, the unusually thick, lipid-rich envelope imposes additional constraints on the movement of peptidoglycan precursors and fragments, and transport processes are tightly coordinated with envelope biogenesis. Beyond bacteria, host organisms can transport bacterial peptidoglycan fragments to sense infection; for example, the mammalian transporter SLC46A2 mediates uptake of muropeptides and contributes to immune responses in psoriatic skin inflammation. Thus, peptidoglycan transport is a fundamental process at the interface of bacterial physiology, antibiotic action, and host-microbe interactions.
peptidoglycan transport At A Glance
| GO ID | GO:0015835 |
|---|---|
| GO term | peptidoglycan transport |
| Ontology | biological_process |
| Synonym | murein transport |
| Major function | Directed movement of peptidoglycan glycoconjugates across membranes via transporters or pores |
| Biological context | Bacterial cell wall synthesis, remodeling, and recycling; host sensing of bacterial fragments |
| Cellular location | Cytoplasmic membrane, periplasm, outer membrane, and host endosomal membranes |
| Representative transporters | AmpG, SLC46A2, and other peptidoglycan recycling permeases |
| Disease relevance | Antibiotic resistance, bacterial pathogenesis, and inflammatory skin diseases such as psoriasis |
What Is GO:0015835?
According to the Gene Ontology, GO:0015835 peptidoglycan transport is defined as the directed movement of peptidoglycans, a class of glycoconjugates found in bacterial cell walls, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. The synonym murein transport is also used. This term falls under the biological_process aspect of the ontology. In practice, it encompasses the activities of membrane-embedded permeases, ABC transporters, and pore-forming proteins that recognize and translocate peptidoglycan fragments or precursors across biological membranes, as well as the transport steps that feed into peptidoglycan recycling and cell wall synthesis.
Why Is peptidoglycan transport Important in Cell Biology?
Peptidoglycan transport is essential because the peptidoglycan sacculus is a dynamic structure that must be continuously remodeled during bacterial growth and division, and the fragments generated by this remodeling need to be transported for recycling or signaling. In Escherichia coli, multiple peptidoglycan recycling permeases with distinct strategies ensure efficient recovery of muropeptides, linking transport directly to cell wall integrity and resistance to antibiotics. In mycobacteria, the complex envelope architecture requires coordinated transport of peptidoglycan precursors and fragments to maintain the permeability barrier and intrinsic drug resistance. In host organisms, transport of bacterial peptidoglycan fragments by SLC46A2 can trigger immune responses, and inhibition of this transporter suppresses psoriatic skin inflammation, highlighting the therapeutic potential of targeting peptidoglycan transport. Furthermore, antibiotics such as bacitracin indirectly affect peptidoglycan transport by interfering with the lipid carrier cycle, underscoring the clinical importance of this process.
• Peptidoglycan transport is required for bacterial cell wall recycling, allowing reuse of muropeptides and conservation of metabolic resources.
• It contributes to intrinsic antibiotic resistance by removing or recycling cell wall-targeting agents and maintaining envelope integrity.
• Transporters such as AmpG are essential for beta-lactamase induction in Gram-negative bacteria, linking transport to antibiotic resistance signaling.
• In Mycobacterium tuberculosis, peptidoglycan transport is part of the complex envelope biogenesis machinery that underlies intrinsic drug resistance.
• Host peptidoglycan transporters like SLC46A2 mediate immune sensing of bacteria and are implicated in inflammatory diseases such as psoriasis.
• Bacitracin, a clinical antibiotic, targets the lipid carrier cycle that supplies peptidoglycan precursors, indirectly affecting transport and synthesis.
• Peptidoglycan transport is a potential target for new antibacterial agents that disrupt cell wall homeostasis.
• Understanding peptidoglycan transport informs the design of CRISPR-based screens for genes involved in cell envelope biogenesis.
• Dysregulation of peptidoglycan transport can alter outer membrane asymmetry and cell envelope homeostasis, with consequences for virulence.
• Peptidoglycan transport is a model system for studying membrane protein function and substrate specificity in bacteria.
What Happens During peptidoglycan transport?
Generation of peptidoglycan fragments in the periplasm
In simple terms: Bacteria constantly break down and rebuild their cell wall, releasing small pieces that need to be moved.
During bacterial growth and division, peptidoglycan is continuously remodeled by lytic transglycosylases, endopeptidases, and amidases, generating soluble muropeptides in the periplasm. These fragments include anhydro-muropeptides and other breakdown products that can be recycled or used as signaling molecules. In Escherichia coli, the periplasmic pool of muropeptides is a substrate for multiple recycling permeases, and the composition of this pool reflects the activity of cell wall hydrolases. The generation of these fragments is the first step that necessitates peptidoglycan transport, as they must cross the cytoplasmic membrane to reach the recycling machinery.
Recognition and translocation by peptidoglycan permeases
In simple terms: Specialized transporter proteins in the bacterial membrane recognize the cell wall pieces and carry them into the cell.
Peptidoglycan transport is mediated by membrane-embedded permeases that recognize muropeptides and translocate them across the cytoplasmic membrane. In E. coli, AmpG is a well-characterized permease that imports anhydro-muropeptides, while additional permeases with distinct substrate preferences contribute to recycling. These transporters are often members of the major facilitator superfamily or other secondary transporter families, and their activity is coupled to ion gradients or ATP hydrolysis. The specificity of these permeases ensures that only appropriate fragments are internalized, preventing wasteful or toxic accumulation of peptidoglycan intermediates. The coordinated action of multiple permeases allows E. coli to utilize different recycling strategies under varying growth conditions.
Intracellular processing and recycling of transported muropeptides
In simple terms: Once inside, the cell wall pieces are broken down further and reused to build new cell wall.
After transport into the cytoplasm, muropeptides are processed by enzymes such as NagZ, AmpD, and LdcA to release sugars and peptides that can re-enter central metabolism or be reused for peptidoglycan synthesis. In E. coli, the recycling pathway converges on the formation of UDP-N-acetylglucosamine and other precursors, which are then translocated back to the periplasm for cell wall assembly. This recycling loop reduces the need for de novo synthesis and contributes to cell wall homeostasis. Defects in transport or downstream processing can lead to accumulation of muropeptides, altered beta-lactamase induction, and increased susceptibility to antibiotics.
Transport of peptidoglycan precursors for cell wall synthesis
In simple terms: Building blocks of the cell wall are also moved across the membrane to the outside where they are assembled.
In addition to recycling, peptidoglycan transport encompasses the movement of lipid-linked precursors such as Lipid II from the inner leaflet of the cytoplasmic membrane to the periplasmic face, where they are incorporated into the growing sacculus. This transport step is mediated by flippases and other membrane proteins, and it is essential for cell wall elongation and division. The lipid carrier undecaprenyl phosphate cycles between the cytoplasmic and periplasmic leaflets, and its availability is a bottleneck for peptidoglycan synthesis. Bacitracin inhibits the dephosphorylation of undecaprenyl pyrophosphate, thereby indirectly blocking peptidoglycan transport and synthesis. Thus, precursor transport is a critical node for antibiotic action.
Host-mediated transport of peptidoglycan fragments
In simple terms: Animals can take up bacterial cell wall pieces to sense infection and trigger immune responses.
Mammalian hosts express transporters that can internalize bacterial peptidoglycan fragments, contributing to immune surveillance. SLC46A2 is a muropeptide transporter that mediates the uptake of peptidoglycan fragments into host cells, leading to activation of innate immune signaling. In psoriatic skin inflammation, inhibition of SLC46A2 activity suppresses inflammatory responses, suggesting that peptidoglycan transport is a therapeutic target in inflammatory skin diseases. This host-mediated transport highlights the inter-kingdom relevance of GO:0015835 and its role in microbiome-host interactions.
Key Genes Involved in GO:0015835 peptidoglycan transport
The following genes and proteins are experimentally implicated in peptidoglycan transport or its regulation, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ampG | Muropeptide permease in Escherichia coli; imports anhydro-muropeptides for recycling | Model for studying substrate specificity and beta-lactamase induction |
| ampD | Cytoplasmic amidase that processes transported muropeptides | Links transport to recycling and antibiotic resistance |
| nagZ | Beta-N-acetylglucosaminidase involved in muropeptide recycling | Downstream enzyme of peptidoglycan transport |
| ldcA | LD-carboxypeptidase that recycles muropeptide peptides | Contributes to cell wall recycling after transport |
| mrcA | Penicillin-binding protein 1A; synthesizes peptidoglycan using transported precursors | Connects precursor transport to cell wall assembly |
| mrcB | Penicillin-binding protein 1B; transpeptidase/transglycosylase | Target of beta-lactams; requires Lipid II transport |
| ftsI | Penicillin-binding protein 3; essential for septal peptidoglycan synthesis | Requires coordinated transport of precursors during division |
| murJ | Flippase that translocates Lipid II across the cytoplasmic membrane | Directly mediates peptidoglycan precursor transport |
| mviN | Alternative name for MurJ; essential for peptidoglycan synthesis | Studied for its role in Lipid II transport |
| bacA | Undecaprenyl pyrophosphate phosphatase; affects lipid carrier recycling | Target of bacitracin; indirectly affects peptidoglycan transport |
| uppP | Undecaprenyl pyrophosphate phosphatase; regenerates lipid carrier | Involved in the lipid cycle that supplies transport substrates |
| slc46a2 | Mammalian muropeptide transporter; mediates uptake of bacterial fragments | Therapeutic target in psoriasis and immune sensing |
| slc46a3 | Mammalian transporter with similarity to SLC46A2; may transport related substrates | Potential role in host-microbe interactions |
| lpoA | Outer membrane lipoprotein that activates PBP1A | Links outer membrane asymmetry to peptidoglycan synthesis |
| lpoB | Outer membrane lipoprotein that activates PBP1B | Coordinates envelope homeostasis with peptidoglycan transport |
| mltG | Lytic transglycosylase; generates muropeptides for recycling | Provides substrates for peptidoglycan transport |
| slt70 | Soluble lytic transglycosylase; produces anhydro-muropeptides | Source of transported fragments in E. coli |
| pbp1a | Penicillin-binding protein 1A; transpeptidase | Requires transported Lipid II for activity |
How Is peptidoglycan transport Regulated?
Peptidoglycan transport is regulated at multiple levels to match cell wall synthesis with growth and stress conditions. In Escherichia coli, the expression of ampG and other recycling permeases is controlled by the AmpR transcriptional regulator, which senses cytoplasmic muropeptide levels and induces beta-lactamase expression in response to cell wall damage. The activity of peptidoglycan transporters can also be modulated by the availability of substrates and the proton motive force, as many are secondary active transporters. In mycobacteria, envelope stress responses coordinate peptidoglycan synthesis and transport with outer membrane lipid homeostasis, ensuring that the permeability barrier is maintained. Additionally, the lipid carrier cycle that supplies precursors for transport is regulated by undecaprenyl pyrophosphate phosphatases such as BacA and UppP, which are targets of bacitracin. In host cells, SLC46A2-mediated transport of muropeptides is regulated by inflammatory signals, and its inhibition can suppress psoriatic inflammation. Overall, peptidoglycan transport is integrated with cell envelope stress responses and metabolic cues to maintain homeostasis.
peptidoglycan transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ampG | Beta-lactam resistance in Gram-negative infections | E. coli knockout and overexpression strains for antibiotic susceptibility testing |
| slc46a2 | Psoriasis and inflammatory skin disease | Mouse models of psoriasis with Slc46a2 knockout or pharmacological inhibition |
| murJ | Bacterial cell wall synthesis and viability | Conditional knockout in E. coli to study Lipid II transport |
| bacA | Bacitracin resistance and lipid carrier metabolism | BacA knockout in Bacillus subtilis or E. coli |
| lpoA/lpoB | Outer membrane asymmetry and envelope stress | Knockout mutants in E. coli for envelope permeability assays |
Antibiotic resistance and bacterial infections
Peptidoglycan transport is directly linked to antibiotic resistance because recycling permeases such as AmpG are required for the induction of chromosomal beta-lactamases in Gram-negative bacteria. Disruption of peptidoglycan transport can sensitize bacteria to beta-lactams and other cell wall-targeting antibiotics, making transporters attractive targets for adjuvant therapy. In Mycobacterium tuberculosis, the complex envelope and transport systems contribute to intrinsic resistance to many antibiotics, and understanding peptidoglycan transport may reveal new drug targets. Bacitracin, which interferes with the lipid carrier cycle, demonstrates that blocking peptidoglycan precursor transport is a validated antibacterial strategy.
Inflammatory skin diseases and host immune sensing
Host-mediated transport of bacterial peptidoglycan fragments by SLC46A2 contributes to immune activation and has been implicated in psoriatic skin inflammation. Inhibition of SLC46A2 activity suppresses psoriatic inflammation in experimental models, suggesting that targeting peptidoglycan transport in host cells could be therapeutic for inflammatory skin diseases. This highlights the dual role of peptidoglycan transport in both bacterial physiology and host-pathogen interactions.
Cell envelope homeostasis and outer membrane asymmetry
Peptidoglycan transport is functionally intertwined with outer membrane asymmetry in Gram-negative bacteria. Perturbations in peptidoglycan integrity can alter outer membrane lipid composition and permeability, affecting susceptibility to antibiotics and host defense molecules. The interplay between peptidoglycan transport and outer membrane homeostasis is an emerging area of research with implications for understanding bacterial stress responses.
From peptidoglycan transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of ampG reduce beta-lactamase induction? | E. coli ampG knockout (CRISPR-Cas9) |
| Can point mutations in murJ alter Lipid II transport? | E. coli murJ point-mutant knock-in |
| Does SLC46A2 overexpression increase muropeptide uptake? | HEK293 or keratinocyte overexpression of SLC46A2 |
| What is the subcellular localization of AmpG? | Tagged knock-in of ampG with fluorescent protein in E. coli |
| Does knockout of lpoA affect outer membrane asymmetry? | E. coli lpoA knockout |
| Can CRISPR library screening identify new peptidoglycan transport genes? | Genome-wide CRISPR knockout library in E. coli or mammalian cells |
How to Study the peptidoglycan transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout library screening | Gene fitness effects under selection | Identify novel peptidoglycan transport genes |
| Radiolabeled muropeptide transport assay | Uptake kinetics and substrate specificity | Characterize AmpG and other permeases |
| Fluorescence microscopy | Localization of transporters and peptidoglycan | Visualize transport dynamics in live cells |
| Cryo-EM | High-resolution structure of transporters | Determine substrate binding and mechanism |
| RNA-seq | Transcriptional response to envelope stress | Study regulation of transport genes |
| Proteomics | Protein abundance and interactions | Identify transport complexes and regulators |
| Flow cytometry | Muropeptide uptake in host cells | Measure SLC46A2 activity |
| Bioinformatics pathway enrichment | Functional annotation of screen hits | Link transport genes to cell wall pathways |
Genetic screens and CRISPR libraries
Genome-wide CRISPR knockout or interference libraries can be used to identify genes required for peptidoglycan transport and recycling, as demonstrated by studies that uncovered multiple permeases in E. coli. These screens typically use fitness readouts under antibiotic selection or in defined media, followed by next-generation sequencing to quantify guide RNA enrichment. Such approaches can also be applied to host cells to discover transporters like SLC46A2 involved in muropeptide uptake.
Biochemical transport assays
Direct measurement of peptidoglycan transport can be achieved using radiolabeled or fluorescently labeled muropeptides in proteoliposome or whole-cell assays. These assays allow determination of substrate specificity, kinetics, and energy coupling for transporters such as AmpG. In host cells, uptake of labeled muropeptides can be quantified by flow cytometry or microscopy to study SLC46A2 activity.
Structural and imaging approaches
Cryo-electron microscopy and X-ray crystallography can resolve the structures of peptidoglycan transporters, revealing substrate-binding pockets and translocation pathways. Fluorescence microscopy with tagged transporters and peptidoglycan stains can visualize the spatial organization of transport and cell wall synthesis in live bacteria. These methods are complemented by super-resolution imaging to track muropeptide movement across membranes.
Omics and bioinformatics
Transcriptomics and proteomics can reveal how peptidoglycan transport genes are regulated under different conditions, such as antibiotic exposure or host infection. Comparative genomics and phylogenetic analysis can identify conserved transporters across bacterial species, guiding functional studies. Bioinformatics pipelines for CRISPR screen analysis are essential for hit calling and pathway enrichment.
How CRISPR Can Be Used to Study GO:0015835 peptidoglycan transport
Knockout
CRISPR-Cas9 knockout of peptidoglycan transport genes such as ampG in E. coli can be used to study their role in beta-lactamase induction and antibiotic resistance. Knockout of murJ is lethal unless complemented, demonstrating its essentiality for Lipid II transport. In mammalian cells, knockout of SLC46A2 can abolish muropeptide uptake and reduce inflammatory signaling.
Point Mutation
Point mutations in transporter genes can be introduced by CRISPR prime editing or homology-directed repair to dissect substrate specificity and catalytic residues. For example, mutations in the predicted substrate-binding pocket of MurJ can reveal residues critical for Lipid II translocation. Similarly, point mutations in SLC46A2 can identify residues required for muropeptide recognition.
Knock-in
Knock-in of fluorescent or epitope tags into endogenous transport genes allows real-time visualization and purification of transporter complexes. Tagged AmpG knock-in strains can be used to monitor protein levels and localization under different growth conditions. Knock-in of disease-associated variants into host transporters can model altered muropeptide uptake in inflammatory diseases.
Overexpression
Overexpression of peptidoglycan transporters can increase transport capacity and reveal dose-dependent effects on cell wall synthesis and antibiotic susceptibility. In host cells, overexpression of SLC46A2 can enhance immune responses to bacterial fragments, providing a gain-of-function model for studying inflammation. Overexpression of lipid carrier phosphatases such as BacA can also modulate the supply of precursors for transport.
How EDITGENE Supports peptidoglycan transport Research
Researchers studying peptidoglycan transport-related genes often need to determine whether a candidate gene is causally involved in muropeptide uptake, recycling, or host immune sensing. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models that enable such causal inferences.
Contact EDITGENE today to design your custom CRISPR model for peptidoglycan transport research.
Frequently Asked Questions About peptidoglycan transport
What is peptidoglycan transport?
Peptidoglycan transport (GO:0015835) is the directed movement of peptidoglycans, a class of glycoconjugates found in bacterial cell walls, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
What genes are involved in peptidoglycan transport?
Key genes include ampG, murJ, ampD, nagZ, ldcA, and slc46a2, which encode transporters and processing enzymes for muropeptides.
Why is peptidoglycan transport important for bacteria?
It is essential for cell wall recycling, maintenance of envelope integrity, and induction of beta-lactamase resistance, making it a target for antibiotics.
How is peptidoglycan transport studied?
Researchers use CRISPR knockout screens, radiolabeled transport assays, cryo-EM, fluorescence microscopy, and omics approaches to study peptidoglycan transport.
What diseases are linked to peptidoglycan transport?
Dysregulation of peptidoglycan transport is linked to antibiotic-resistant infections and inflammatory skin diseases such as psoriasis through SLC46A2.
What is the role of SLC46A2 in peptidoglycan transport?
SLC46A2 is a mammalian transporter that mediates uptake of bacterial muropeptides and contributes to immune activation in psoriasis.
How does bacitracin affect peptidoglycan transport?
Bacitracin inhibits the dephosphorylation of undecaprenyl pyrophosphate, indirectly blocking the lipid carrier cycle that supplies precursors for peptidoglycan transport and synthesis.
Can CRISPR be used to study peptidoglycan transport?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional dissection of peptidoglycan transport genes.
What is the difference between peptidoglycan transport and synthesis?
Transport refers to the movement of peptidoglycan fragments or precursors across membranes, while synthesis refers to the enzymatic assembly of the peptidoglycan polymer.
Which model organisms are used to study peptidoglycan transport?
Escherichia coli, Mycobacterium tuberculosis, Bacillus subtilis, and mammalian cell lines are commonly used to study peptidoglycan transport.
Conclusion
Peptidoglycan transport (GO:0015835) is a fundamental biological process that governs the movement of muropeptides and precursors across membranes, with critical roles in bacterial cell wall recycling, antibiotic resistance, and host immune sensing. Understanding the genes and mechanisms involved provides opportunities for developing new antibacterial strategies and therapies for inflammatory diseases. Advanced CRISPR tools and bioinformatics now enable precise interrogation of this process in diverse model systems.
References
- 1. Garde S et al.. 2021. Peptidoglycan: Structure, Synthesis, and Regulation.. EcoSal Plus 9(2) PMID: 33470191
- 2. Brennan PJ et al.. 1995. The envelope of mycobacteria.. Annu Rev Biochem 64:29-63 PMID: 7574484
- 3. Gilmore MC et al.. 2025. Bacterial peptidoglycan recycling.. Trends Microbiol 33(3):340-353 PMID: 39613687
- 5. Simpson BW et al.. 2023. Escherichia coli utilizes multiple peptidoglycan recycling permeases with distinct strategies of recycling.. Proc Natl Acad Sci U S A 120(44):e2308940120 PMID: 37871219
- 6. Toscano WA Jr et al.. 1982. Bacitracin.. Pharmacol Ther 16(2):199-210 PMID: 6752975
- 7. Bharadwaj R et al.. 2023. Methotrexate suppresses psoriatic skin inflammation by inhibiting muropeptide transporter SLC46A2 activity.. Immunity 56(5):998-1012.e8 PMID: 37116499
- 8. Nandy S et al.. 2025. Molecular interplay between peptidoglycan integrity and outer membrane asymmetry in maintaining cell envelope homeostasis.. J Bacteriol 207(10):e0033125 PMID: 40965224
